Tirzepatide is a groundbreaking pharmaceutical agent for individuals battling type 2 diabetes. As a dual agonist, it targets both the glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide https://miriamenlh257841.anchor-blog.com/20970152/tirzepatide-a-game-changer-for-type-2-diabetes